This is a routine insider intent-to-sell filing with immaterial size. Monitor for any subsequent Form 4 filings to confirm execution, but no further action warranted.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $386.48entry
- T+1 · 6d ago −0.12%α −1.44% · $386.00
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Jonathan P. DiVincenzo, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 919 shares of common stock, with an approximate market value of $359,000 based on the filing. The shares were acquired as restricted stock on October 24, 2025, and the proposed sale is scheduled for November 9, 2026. The sale represents a small fraction of the company's $9.9B market cap and is likely a routine diversification trade by an officer.
Key Facts
- Jonathan P. DiVincenzo, an officer of Bio-Rad, filed Form 144 to sell 919 shares of common stock.
- The approximate market value of the proposed sale is $358,842 (based on 919 shares at the filing reference price of ~$390.47 per share).
- Shares were acquired as restricted stock on October 24, 2025, via an issuer transaction.
- The proposed sale date is November 9, 2026.
- The sale represents about 0.0036% of Bio-Rad's $9.9B market cap, a de minimis amount.
Financial Impact
919 shares, approximately $359,000 in value, negligible relative to $9.9B market cap
Risk Factors
- Form 144 is only an intent to sell; the sale may not occur.
- No additional context on the insider's total holdings is provided, so the proportional impact on his position is unknown.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010897 |
| Document: 0001950047-26-010897-index.html | 0001950047-26-010897 |
| Document: 0001950047-26-010897.txt | 0001950047-26-010897 |
Track record
9 reports on BIO
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $370.48 Now $360.26 −2.76% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $386.00 Now $360.26 −6.67% settles Nov 18
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $386.48 Now $360.26 −6.78% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $386.48 Now $360.26 −6.78% settles Nov 17
- Nov 6, 202610d ago Institutional Cluster Bearish 4/10 Entry $388.31 to $360.26 Now $360.26 +7.22% ▲ +7.22% +5.53% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $369.00 to $370.48 Now $360.26 −2.37% ▲ +0.40% −2.89% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $385.12 to $379.99 Now $360.26 −6.46% ▼ −1.33% −0.62% vs SPY
- Sep 10, 20269w ago Court Ruling Bearish 5/10 Entry $369.32 to $376.41 Now $360.26 +2.45% ▼ −1.92% −2.26% vs SPY
- Jun 12, 202622w ago Institutional Cluster Mixed 5/10 Entry $285.94 to $282.44 Now $360.26 +25.99% ▼ −1.22% −1.90% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers